Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection.

Eagleton, Marie; Stokes, Siobhan; Fenton, Fiona; Keenan, Eamon

Eagleton, Marie; Stokes, Siobhan; Fenton, Fiona; Keenan, Eamon.

Eagleton M; HSE National Drug Treatment Centre, Dublin 2, Ireland. Electronic address: meagleton@dtcb.ie.
Stokes S; HSE National Drug Treatment Centre, Dublin 2, Ireland.
Fenton F; HSE National Drug Treatment Centre, Dublin 2, Ireland.
Keenan E; Health Service Executive, National Social Inclusion Office, Dublin, Ireland.

Br J Anaesth ; 127(6): e212-e214, 2021 12.

Article in English | MEDLINE | ID: covidwho-1437403

Subject(s)

Analgesics, Opioid/therapeutic use; COVID-19 Drug Treatment; Narcotic Antagonists/therapeutic use; Opioid-Related Disorders/drug therapy; COVID-19/epidemiology; COVID-19/immunology; Humans; Opioid-Related Disorders/epidemiology; Opioid-Related Disorders/immunology

Keywords

ACE-2 receptor; COVID-19; SARS-CoV-2; TLR-4; naltrexone; opioid antagonists; opioid substitution treatment; opioid use disorder; opioids

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Analgesics, Opioid / Narcotic Antagonists / Opioid-Related Disorders Type of study: Observational study Limits: Humans Language: English Journal: Br J Anaesth Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google